CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation-Reference-Cited by-同舟云学术

CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation

Published:2015-10-26 Issue:38 Volume:6 Page:41092-41107
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Baocai¹,Su Yu¹²,Li Ting¹,Yuan Wanqiong¹,Mo Xiaoning¹,Li Henan¹³,He Qihua⁴,Ma Dalong¹,Han Wenling¹

Affiliation:

1. Center for Human Disease Genomics, Department of Immunology, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing, China

2. Department of Clinical Laboratory, Beijing Jishuitan Hospital, Beijing, China

3. Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China

4. Peking University Medical and Health Analysis Center, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors;PeerJ;2024-01-10

2. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling;Cellular Signalling;2023-12

3. Loss of the Novel Myelin Protein CMTM5 in Multiple Sclerosis Lesions and Its Involvement in Oligodendroglial Stress Responses;Cells;2023-08-17

4. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling;Breast Cancer Research;2023-02-24

5. CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma;Current Oncology;2023-02-22